Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Change in Acquisitions & Divestments: 2022-2023

  • Therapeutics' Change in Acquisitions & Divestments fell 73.83% to $21.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $192.8 million, marking a year-over-year change of. This contributed to the annual value of $87.9 million for FY2024, which is 290.67% up from last year.
  • Latest data reveals that Therapeutics reported Change in Acquisitions & Divestments of $21.0 million as of Q4 2023, which was up 1,300.00% from $1.5 million recorded in Q3 2023.
  • Therapeutics' 5-year Change in Acquisitions & Divestments high stood at $90.0 million for Q3 2022, and its period low was $1.5 million during Q3 2023.
  • Over the past 2 years, Therapeutics' median Change in Acquisitions & Divestments value was $50.6 million (recorded in 2022), while the average stood at $48.2 million.
  • Data for Therapeutics' Change in Acquisitions & Divestments shows a maximum YoY tumbled of 98.33% (in 2023) over the last 5 years.
  • Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $80.2 million in 2022, then crashed by 73.83% to $21.0 million in 2023.
  • Its Change in Acquisitions & Divestments stands at $21.0 million for Q4 2023, versus $1.5 million for Q3 2023 and $80.2 million for Q4 2022.